Anseryah
"Anseryah" is a trademark owned by Novo Nordisk Health Care AG, filed at the WIPO on March 14, 2024. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Filed
- March 14, 2024
- Registered
- Not yet
- Expires
- March 14, 2034
- Application no.
- Not recorded
- Registration no.
- 1793364
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 1 class
Who owns Anseryah
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Novo Nordisk Health Care AG
Switzerland
Representative
Isler & Pedrazzini AG
Isler & Pedrazzini AG
What the mark covers
The products and services Anseryah is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of hematological conditions, pharmaceutical preparations for the treatment of anemia, pharmaceutical preparations for the treatment of sickle cell disease.
About Anseryah
Who owns the trademark "Anseryah"?
The WIPO trademark "Anseryah" is owned by Novo Nordisk Health Care AG.
What is the status of "Anseryah"?
Its status at the WIPO is: registered.
Get this data via the API
Everything on this page comes from the Signa API. Pull Anseryah and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_979c2bb3-ec9d-4215-8ef0-bd1536ab8d4a
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_979c2bb3-ec9d-4215-8ef0-bd1536ab8d4a",
"object": "trademark",
"mark_text": "Anseryah",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2024-03-14",
"nice_classes": [
5
],
"owners": [
{
"name": "NOVO NORDISK HEALTH CARE AG",
"entity_id": "ent_019eb6fb-c8d8-774d-8f4b-f2b88f5c8227"
}
]
}